Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

CAPS Rating: 2 out of 5

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Recs

0
Player Avatar headyinvestor (61.01) Submitted: 1/11/2012 8:09:20 AM : Outperform Start Price: $1.70 ARNA Score: +68.14

Pick up post dilution, ride it to a month before the PDUFA

Featured Broker Partners


Advertisement